UNSPSC 51183306: Sitagliptin phosphate

This classification denotes a protease inhibitor and anti-diabetic agent with the molecular structure C16H15F6N5O.H2O.H3O4P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, TS63EW8X6F chemically known as 1,2,4-triazolo(4,3-a)pyrazine, 7-((3r)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl)-5,6,7,8-tetrahydro-3-(trifluoromethyl), phosphate (1:1) monohydrate, but more commonly known as sitagliptin phosphate, which bears US NIH Compound Identifier 11591741.

UNSPSC 51183306 Sitagliptin phosphate, a Commodity code, covers the procurement of this specific generic antidiabetic pharmaceutical in state and local health care and corrections settings. State and local governments buy sitagliptin phosphate primarily through multi-source pharmaceutical contracts that establish pricing and supply agreements with manufacturers, requiring compliance with cGMP, FDA requirements, and the Drug Supply Chain Security Act (DSCSA). The drug is typically sourced via authorized wholesale distributors (such as AmerisourceBergen/Cencora, Cardinal Health, and Morris & Dickson) and supplied to state health agencies, Medicaid programs, correctional health systems, and other covered entities under cooperative purchasing agreements. Issuing bodies include state departments of administration and health, often operating through multistate cooperative purchasing alliances that aggregate demand across multiple jurisdictions to negotiate better pricing and supply terms.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products including sitagliptin phosphate, with participating members spanning Minnesota, Oregon, and other affiliated states and local entities. MMCAP evaluated proposals on price competitiveness (75 percent weight), fixed pricing for the contract term (10 percent), and compliance with administrative data format, EDI capability, and the required 3 percent administrative fee (each 5 percent). Vendors must maintain contractual relationships with at least two of the three authorized wholesalers, certify cGMP and DSCSA compliance, carry comprehensive insurance including $5 million commercial general liability, and ensure products carry expiration dates at least one year from manufacture with a minimum six-month shelf life. Contract term is two years for new vendors, effective July 1, 2026, with performance penalties of $200 to $1,500 per violation for late reporting or missed onboarding timelines.